Editorial
Copyright ©2010 Baishideng Publishing Group Co.
World J Stem Cells. Aug 26, 2010; 2(4): 67-80
Published online Aug 26, 2010. doi: 10.4252/wjsc.v2.i4.67
Table 1 Examples of in vivo applications of mesenchymal stem cells
AnimalDisease modelOutcome
BaboonSkin graft transplantationProlonged skin graft survival[169]
MouseGvHDPrevention of GvHD[124,170]
EAEPrevention of EAE development and improved functional recovery[129,171]
CIAImproved arthritic symptoms[172]
NODPrevent T-cell mediated beta-cell destruction[173]
SLEImproved symptoms, serological markers and renal function[137]
Lung injuryDecreased severity of endotoxin induced lung injury and improved survival[174]
RatGlomerulonephritisAccelerate glomerular healing[175]
Critical size defectImproved healing and function[176]
Experimental colitisImproved survival and healing[177]
Dilated rat cardiomyopathyImproved cardiac function[178]
Heart transplantationParticipate in tissue repair by giving rise to myofibroblasts and cardiomyocytes[179]
Myocardial infarctionImproved cardiac function and survival[143]
Cerebral ischemiaReduced gross lesion volume and improved functional recovery[151]
Table 2 Examples of the therapeutic applications of mesenchymal stem cells in humans
IndicationsSourceRout of administrationOutcome
Myocardial infarctionAllogenic BMIVIncreased GSS and EF[148]
Autologous BMIntracoronaryImproved LVF[149]
Cartilage defectAutologous BMDirect site transplantationImproved clinical symptom and coverage of defect[110]
Osteogenesis imperfectaAllogenic BMIVGrowth acceleration[117]
Fetal MSCIntrauterine transplantationOsteoblastic differentiation and reduced fracture[119]
Critical size defectAutologous BMScaffold loadedFaster full recovery of limb function than bone graft[103]
MLD and hurler syndromeAllogenic BMIVImproved nerve conduction velocity in MLD patient and increased bone mineral density[167]
Severe idiopathic aplastic anemiaAllogenic BMIVImproved stroma[168]
Crohn's diseaseAdipose derived stem cellIntralesionalImproved fistula and quality of life[136]

  • Citation: Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells 2010; 2(4): 67-80
  • URL: https://www.wjgnet.com/1948-0210/full/v2/i4/67.htm
  • DOI: https://dx.doi.org/10.4252/wjsc.v2.i4.67